Discover Regeneron Pharmaceuticals' Q3 2025 financial performance, highlighting revenue growth, net income rise, and R&D investments amid litigation risks. A must-read for investors!
Explore Regeneron Pharmaceuticals' 8-K filing from October 28, 2025, detailing crucial updates. Learn more about stock performance and regulatory compliance.
Explore Regeneron Pharmaceuticals' 8-K filing from October 6, 2025, detailing significant events, stock info, and investor insights.
Explore Regeneron Pharmaceuticals' 8-K filing detailing significant corporate events on August 1, 2025. Stay informed on shareholder impacts and market changes.
Discover Regeneron Pharmaceuticals' June 13, 2025, 8-K filing, detailing key corporate events and stock info essential for investors.
Explore Regeneron Pharmaceuticals' Q1 2025 financial performance. Key insights show strong earnings and R&D focus, but declining sales and legal risks warrant a 'Hold' recommendation.
Explore Regeneron Pharmaceuticals' 8-K report detailing significant developments on April 29, 2025. Essential insights for investors and analysts tracking REGN on NASDAQ.
Discover Regeneron Pharmaceuticals' latest 8-K report detailing crucial financial updates and stock information as of January 13, 2025. Stay informed on market impacts!